Description
This medicine selectively inhibits neuraminidase that is on the surface of type A/B influenza virus, prevents release of newly-produced virus from infected cells and suppresses the growth of influenza virus.
It is usually used to prevent type A/B influenza virus infection.
PresentationFeature
Dosage form : Inhaled dry powder
Active Ingredients
Laninamivir octanoate hydrate
Effect/Efficacy
This medicine selectively inhibits neuraminidase that is on the surface of type A/B influenza virus, prevents release of newly-produced virus from infected cells and suppresses the growth of influenza virus.
It is usually used to prevent type A/B influenza virus infection.
Usage/Dosage
[for prevention ]
In general, for adults/children aged 10 years or more, inhale a dose of 2 packages once a day or inhale a dose of 1 package once a day for 2 consecutive days. For children aged under 10 years, inhale a dose of 1 package once a day. This product contains 20 mg of laninamivir octanoate in a package and the medicine is filled in 2 parts of the package. Strictly follow the instructions.
The medicine is only for oral inhalation use. Read the instruction for users (available only in Japanese) thoroughly before using the medicine.
If you miss a dose, inhale the missed dose as soon as possible.
If you accidentally inhale more than your prescribed dose, consult with your doctor or pharmacist.
Do not stop inhaling this medicine unless your doctor instructs you to do so.
[for treatment]
In general, for adults/children aged 10 years or more, inhale a dose of 2 packages once a day. For children aged under 10 years, inhale a dose of 1 package once a day. This product contains 20 mg of laninamivir octanoate in a package and the medicine is filled in 2 parts of the package. Strictly follow the instructions.
The medicine is only for oral inhalation use. Read the instruction for users (available only in Japanese) thoroughly before using the medicine.
Do not stop inhaling this medicine unless your doctor instructs you to do so.
Cautions
If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
If you have an allergy to dairy products.
If you are pregnant or breastfeeding.
If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
Abnormal behavior has been reported in patients infected with influenza, regardless of the use or non-use, or the type of influenza antiviral medicine prescribed. Therefore it is important to prevent possible troubles including abnormal behavior resulting in fall accidents.
Caregivers should take preventive measures for accidents including falls for at least 2 days after patients develop pyrexia if they are treated at home. Severe abnormal behavior is known to have been reported to occur with greater frequency in male school-age children/adolescents.
Keep out of reach of children. Store away from direct sunlight, heat and moisture.
Discard the remainder. Do not store them.
Contraindication
The most commonly reported adverse reactions include diarrhea and headache. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
breathing difficulty, hives, decrease of blood pressure, pale face, cold sweat [shock, anaphylaxis]
fitful shortness of breath, wheezing (whistling breath), breathing difficulty, shortness of breath on exertion [bronchospasm, respiratory distress]
sudden movement, wandering [abnormal behavior]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
